These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6104347)

  • 21. Effect of insulin treatment on prostacyclin in experimental diabetes.
    Harrison HE; Reece AH; Johnson M
    Diabetologia; 1980 Jan; 18(1):65-8. PubMed ID: 6988267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
    Firth BG; Winniford MD; Campbell WB; Hillis LD
    Am J Cardiol; 1983 Sep; 52(5):439-43. PubMed ID: 6351580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 24. Prostacyclin for acute coronary insufficiency.
    Szczeklik A; Szczeklik J; Nizankowski R; Głuszko P
    Artery; 1980; 8(1):7-11. PubMed ID: 6775619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemodynamic effects of prostacyclin (PGI2) in pulmonary hypertension.
    Guadagni DN; Ikram H; Maslowski AH
    Br Heart J; 1981 Apr; 45(4):385-8. PubMed ID: 7013775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease.
    Olsson AG; Nilsson E
    Prostaglandins Med; 1981 Apr; 6(4):329-39. PubMed ID: 7025066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.
    Fineberg SE; Schneider SH
    Diabetologia; 1980 Jan; 18(1):49-54. PubMed ID: 6988265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged infusion of prostacyclin in patients with advanced stages of peripheral vascular disease: a placebo-controlled cross-over study.
    Hossmann V; Auel H; Rücker W; Schrör K
    Klin Wochenschr; 1984 Dec; 62(23):1108-14. PubMed ID: 6394890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits.
    Watanabe M; Watanabe K; Matsui H
    Vet Hum Toxicol; 2002 Jun; 44(3):140-4. PubMed ID: 12046964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of intravenous prostacyclin in variant angina.
    Chierchia S; Patrono C; Crea F; Ciabattoni G; De Caterina R; Cinotti GA; Distante A; Maseri A
    Circulation; 1982 Mar; 65(3):470-7. PubMed ID: 7034990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostacyclin and pathogenesis of hemodynamic abnormalities of diabetic ketoacidosis in rats.
    Quyyumi AA; Iaffaldano R; Guerrero JL; Ryan CA; Powell WJ; Axelrod L
    Diabetes; 1989 Dec; 38(12):1585-94. PubMed ID: 2511053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
    Nadeau A; Catellier C
    Union Med Can; 1974 Mar; 103(3):413-7. PubMed ID: 4820869
    [No Abstract]   [Full Text] [Related]  

  • 33. Insulin responses to nonglucose stimuli in non-insulin-dependent diabetes mellitus during a tolbutamide infusion.
    Pfeifer MA; Halter JB; Beard JC; Judzewitsch R; Porte D
    Diabetes; 1982 Feb; 31(2):154-9. PubMed ID: 6759232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical studies on the vasodilating and anti-platelet effects of OP-41483, a prostacyclin derivative.
    Kusaba A; Shiroma H; Shrestha DR; Koja K; Kina M; Kuniyoshi Y; Iha K; Kinjo O; Akasaki M; Kugai T
    Jpn J Surg; 1991 Jan; 21(1):8-13. PubMed ID: 2041246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute hemodynamic effects of prostacyclin in severe or malignant hypertension].
    Chaignon M; Tannière-Ruffie ML; Lucsko M; Guédon J
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():147-50. PubMed ID: 6810818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of prostacyclin on cerebral vasospasm--an experimental study].
    Quintana L; Konda R; Ishibashi Y; Okada H; Suzuki J
    No Shinkei Geka; 1982 Oct; 10(10):1049-52. PubMed ID: 6757779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease.
    Sinzinger H; Virgolini I; O'Grady J
    Prog Clin Biol Res; 1989; 301():85-96. PubMed ID: 2477859
    [No Abstract]   [Full Text] [Related]  

  • 38. Circadian variation of glucose, insulin, and free fatty acids during long-term use of oral hypoglycaemic agents in diabetes mellitus.
    Rigas AN; Bittles AH; Hadden DR; Montgomery DA
    Br Med J; 1968 Oct; 4(5622):25-8. PubMed ID: 5677210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostacyclin treatment of ischemic ulcers and rest pain in unreconstructible peripheral arterial occlusive disease.
    Cronenwett JL; Zelenock GB; Whitehouse WM; Lindenauer SM; Graham LM; Stanley JC
    Surgery; 1986 Aug; 100(2):369-75. PubMed ID: 3526609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No effect of propranolol and metoprolol on tolbutamide-stimulated insulin-secretion in hypertensive diabetic and non-diabetic patients.
    Tötterman KJ; Groop LC
    Ann Clin Res; 1982 Aug; 14(4):190-3. PubMed ID: 6762846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.